论文部分内容阅读
目的评估石家庄地区输血传播HBV、HCV、HIV的残余风险。方法以石家庄地区2013年1月-2014年12月献血者ELISA筛查数据及其基本资料为基础,采用(WP/I)、(WP/LTR)数学模型分别评估重复献血者及初次献血者传播HBV、HCV、HIV的残余风险。结果 2013年1月-2014年12月石家庄地区献血者,经ELISA检测后输血传播HBV、HCV、HIV的残余风险分别为1∶28 714、1∶41 102、1∶601 506。结论本地区经ELISA检测后存在输血传播病毒残余风险,核酸检测技术(NAT)应用于血液筛查可降低输血传播HBV、HCV、HIV残余风险。
Objective To evaluate the residual risk of transfusion of HBV, HCV and HIV in Shijiazhuang area. Methods Based on the screening data of blood donors in Shijiazhuang from January 2013 to December 2014 and the basic data of the blood donors, the (WP / I) and (WP / LTR) mathematical models were used to assess the transmission of repeated blood donors and primary blood donors Residual risk of HBV, HCV, HIV. Results The residual risk of blood transfusion of HBV, HCV and HIV after blood transfusion in Shijiazhuang from January 2013 to December 2014 were 1:28 714, 1:41 102 and 1:61 506 respectively. Conclusion The residual risk of transfusion transmitted virus (HBV) is detected by ELISA in the region. The application of nucleic acid detection (NAT) in blood screening can reduce the residual risk of transfusion of HBV, HCV and HIV.